{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:34:58Z","timestamp":1789443298397,"version":"build-2803163510"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":549,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Defects in human hemochromatosis protein (HFE) cause iron overload due to reduced hepatic hepcidin secretion. Liver transplantation (LT) is a key treatment for potential complications from HFE-related hereditary hemochromatosis (HH). This study evaluated hepcidin secretion and iron burden after LT to elucidate HH pathophysiology. Patients (n = 18) homozygous for the p.Cys282Tyr mutation in the <jats:italic toggle=\"yes\">HFE<\/jats:italic> gene underwent LT between 1999 and 2008. Serum iron, serum hepcidin, and hepatic iron concentrations were determined before LT and at the end of follow-up (median 57 months). Mortality and causes of death were determined. Survival was compared to that of the overall patient population that received LT. Before LT, serum hepcidin levels were low (0.54 \u00b1 2.5 nmol\/L; normal range: 4-30 nmol\/L). After LT, 11 patients had iron evaluations; none received iron depletion therapy; all had normal transferrin saturation. The mean serum ferritin was 185 (\u00b199) \u03bcg\/L. Magnetic resonance imaging showed that iron overload was absent in nine patients, mild in one patient with metabolic syndrome, and high (180 \u03bcmol\/g) in one patient with hereditary spherocytosis discovered after LT. At the end of follow-up, serum hepcidin was normal in 10 patients (11.12 \u00b1 7.6 nmol\/L; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05) and low in one patient with iron deficiency anemia. Survival was 83% and 67% at 1 and 5 years, respectively. Survival was similar for patients with HH and patients that received LT for other causes. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: In HH, LT normalized hepcidin secretion and prevented recurrence of hepatic iron overload. Survival was similar to that of patients who received LTs for other liver diseases. (HEPATOLOGY 2014;59:839\u2013847)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26570","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T16:03:20Z","timestamp":1371225800000},"page":"839-847","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":50,"title":["Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis"],"prefix":"10.1097","volume":"59","author":[{"given":"Edouard","family":"Bardou-Jacquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lorho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Ropert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Latournerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Houssel-Debry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guyader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lor\u00e9al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Boudjema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20250207","doi-asserted-by":"crossref","first-page":"10171021","DOI":"10.1056\/NEJM197711102971901","article-title":"Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing.","volume":"297","author":"Simon","year":"1977","journal-title":"N Engl J Med"},{"key":"R2-16-20250207","doi-asserted-by":"crossref","first-page":"399408","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class Ilike gene is mutated in patients with hereditary haemochromatosis.","volume":"13","author":"Feder","year":"1996","journal-title":"Nat Genet"},{"key":"R3-16-20250207","doi-asserted-by":"crossref","first-page":"707713","DOI":"10.1016\/j.molmed.2011.07.004","article-title":"Iron disorders of genetic origin: a changing world.","volume":"17","author":"Brissot","year":"2011","journal-title":"Trends Mol Med"},{"key":"R4-16-20250207","doi-asserted-by":"crossref","first-page":"25342539","DOI":"10.1073\/pnas.94.6.2534","article-title":"Immunohistochemistry of HLAH, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract.","volume":"94","author":"Parkkila","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-16-20250207","doi-asserted-by":"crossref","first-page":"14891496","DOI":"10.1053\/gast.2001.29617","article-title":"Molecular aspects of iron absorption and HFE expression.","volume":"121","author":"Parkkila","year":"2001","journal-title":"Gastroenterology"},{"key":"R6-16-20250207","doi-asserted-by":"crossref","first-page":"78067810","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver.","volume":"276","author":"Park","year":"2001","journal-title":"J Biol Chem"},{"key":"R7-16-20250207","doi-asserted-by":"crossref","first-page":"78117819","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liverspecific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.","volume":"276","author":"Pigeon","year":"2001","journal-title":"J Biol Chem"},{"key":"R8-16-20250207","doi-asserted-by":"crossref","first-page":"20902093","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"R9-16-20250207","doi-asserted-by":"crossref","first-page":"979985","DOI":"10.1111\/j.1365-2141.2008.07273.x","article-title":"Serum hepcidin levels are innately low in HFErelated haemochromatosis but differ between C282Yhomozygotes with elevated and normal ferritin levels.","volume":"142","author":"van Dijk","year":"2008","journal-title":"Br J Haematol"},{"key":"R10-16-20250207","doi-asserted-by":"crossref","first-page":"14721477","DOI":"10.1073\/pnas.95.4.1472","article-title":"The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.","volume":"95","author":"Feder","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-16-20250207","doi-asserted-by":"crossref","first-page":"2849428498","DOI":"10.1074\/jbc.C600197200","article-title":"Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing.","volume":"281","author":"Goswami","year":"2006","journal-title":"J Biol Chem"},{"key":"R13-16-20250207","doi-asserted-by":"crossref","first-page":"24922497","DOI":"10.1073\/pnas.95.5.2492","article-title":"HFE gene knockout produces mouse model of hereditary hemochromatosis.","volume":"95","author":"Zhou","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-16-20250207","doi-asserted-by":"crossref","first-page":"361366","DOI":"10.1006\/bcmd.2002.0575","article-title":"Decreased liver hepcidin expression in the Hfe knockout mouse.","volume":"29","author":"Ahmad","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"R15-16-20250207","doi-asserted-by":"crossref","first-page":"173178","DOI":"10.1016\/j.cmet.2007.11.014","article-title":"Hfe acts in hepatocytes to prevent hemochromatosis.","volume":"7","author":"Vujic Spasic","year":"2008","journal-title":"Cell Metab"},{"key":"R16-16-20250207","doi-asserted-by":"crossref","first-page":"33743381","DOI":"10.1182\/blood-2009-09-245209","article-title":"Hepatocytetargeted HFE and TFR2 control hepcidin expression in mice.","volume":"115","author":"Gao","year":"2010","journal-title":"Blood"},{"key":"R18-16-20250207","doi-asserted-by":"crossref","first-page":"851853","DOI":"10.1155\/2008\/961928","article-title":"Is serum hepcidin causative in hemochromatosis? Novel analysis from a liver transplant with hemochromatosis.","volume":"22","author":"Adams","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"R19-16-20250207","doi-asserted-by":"crossref","first-page":"15891592","DOI":"10.1111\/j.1478-3231.2011.02606.x","article-title":"Hepatic iron overload following liver transplantation of a C282y homozygous allograft: a case report and literature review.","volume":"31","author":"Dwyer","year":"2011","journal-title":"Liver Int"},{"key":"R20-16-20250207","doi-asserted-by":"crossref","first-page":"138142","DOI":"10.1097\/MAJ.0b013e3181719b4b","article-title":"Transplantation of a liver with the C282Y mutation into a recipient heterozygous for H63D results in iron overload.","volume":"337","author":"Ismail","year":"2009","journal-title":"Am J Med Sci"},{"key":"R21-16-20250207","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/gut.45.5.783","article-title":"Transplantation of haemochromatosis liver and intestine into a normal recipient.","volume":"45","author":"Adams","year":"1999","journal-title":"Gut"},{"key":"R22-16-20250207","doi-asserted-by":"crossref","first-page":"10821083","DOI":"10.1136\/gut.32.9.1082","article-title":"Transplantation of a donor liver with haemochromatosis: evidence against an inherited intrahepatic defect.","volume":"32","author":"Adams","year":"1991","journal-title":"Gut"},{"key":"R23-16-20250207","doi-asserted-by":"crossref","first-page":"554561","DOI":"10.1097\/00007890-199309000-00012","article-title":"An analysis of liver transplant experience from 37 transplant centers as reported to Medicare.","volume":"56","author":"Kilpe","year":"1993","journal-title":"Transplantation"},{"key":"R24-16-20250207","doi-asserted-by":"crossref","first-page":"237241","DOI":"10.1002\/lt.500010408","article-title":"Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis.","volume":"1","author":"Kowdley","year":"1995","journal-title":"Liver Transpl Surg"},{"key":"R25-16-20250207","doi-asserted-by":"crossref","first-page":"369374","DOI":"10.1002\/lt.500050503","article-title":"Longterm followup after liver transplantation in patients with hepatic iron overload.","volume":"5","author":"Tung","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R26-16-20250207","doi-asserted-by":"crossref","first-page":"16551662","DOI":"10.1002\/hep.20242","article-title":"Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis.","volume":"39","author":"Crawford","year":"2004","journal-title":"Hepatology"},{"key":"R27-16-20250207","doi-asserted-by":"crossref","first-page":"494503","DOI":"10.1016\/j.gastro.2005.05.004","article-title":"Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.","volume":"129","author":"Kowdley","year":"2005","journal-title":"Gastroenterology"},{"key":"R29-16-20250207","doi-asserted-by":"crossref","first-page":"357362","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Noninvasive assessment of hepatic iron stores by MRI.","volume":"363","author":"Gandon","year":"2004","journal-title":"Lancet"},{"key":"R30-16-20250207","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/bmj.306.6894.1726","article-title":"Site of principal metabolic defect in idiopathic haemochromatosis: insights from transplantation of an affected organ.","volume":"306","author":"Dabkowski","year":"1993","journal-title":"BMJ"},{"key":"R31-16-20250207","doi-asserted-by":"crossref","first-page":"351354","DOI":"10.1016\/S0168-8278(05)80668-3","article-title":"Persistent iron overload 4 years after inadvertent transplantation of a haemochromatotic liver in a patient with primary biliary cirrhosis.","volume":"16","author":"Koskinas","year":"1992","journal-title":"J Hepatol"},{"key":"R32-16-20250207","doi-asserted-by":"crossref","first-page":"221230","DOI":"10.1056\/NEJMoa073286","article-title":"Ironoverloadrelated disease in HFE hereditary hemochromatosis.","volume":"358","author":"Allen","year":"2008","journal-title":"N Engl J Med"},{"key":"R34-16-20250207","doi-asserted-by":"crossref","first-page":"97101","DOI":"10.1038\/ng1150","article-title":"Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.","volume":"34","author":"Nicolas","year":"2003","journal-title":"Nat Genet"},{"key":"R35-16-20250207","first-page":"643651","article-title":"Hepatic and cardiac iron overload among patients with endstage liver disease referred for liver transplantation.","volume":"24","author":"OGlasser","year":"2010","journal-title":"Clin Transplant"},{"key":"R36-16-20250207","doi-asserted-by":"crossref","first-page":"882888","DOI":"10.1053\/gast.1997.v112.pm9041250","article-title":"Hemosiderosis in cirrhosis: a study of 447 native livers.","volume":"112","author":"Ludwig","year":"1997","journal-title":"Gastroenterology"},{"key":"R37-16-20250207","doi-asserted-by":"crossref","first-page":"669675","DOI":"10.1097\/00000478-199706000-00007","article-title":"A reappraisal of hepatic siderosis in patients with endstage cirrhosis: practical implications for the diagnosis of hemochromatosis.","volume":"21","author":"Deugnier","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R38-16-20250207","doi-asserted-by":"crossref","first-page":"456460","DOI":"10.1002\/hep.510310227","article-title":"Iron overload in cirrhosisHFE genotypes and outcome after liver transplantation.","volume":"31","author":"Brandhagen","year":"2000","journal-title":"Hepatology"},{"key":"R39-16-20250207","doi-asserted-by":"crossref","first-page":"489495","DOI":"10.1053\/j.gastro.2007.05.054","article-title":"Survival of liver transplant recipients with hemochromatosis in the United States.","volume":"133","author":"Yu","year":"2007","journal-title":"Gastroenterology"},{"key":"R40-16-20250207","doi-asserted-by":"crossref","first-page":"501510","DOI":"10.1002\/hep.23333","article-title":"Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors.","volume":"51","author":"Fracanzani","year":"2010","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26570","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201403000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:00:03Z","timestamp":1738947603000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201403000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26570","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}